Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation

Arianna Bellucci, Orso Bugiani, Bernardino Ghetti, Maria Grazia Spillantini

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Background: Recent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T). Objective: To investigate the occurrence of neuroinflammatory changes in the brain of a patient affected by FTDP-17T associated with the P301S mutation and showing a frontotemporal dementia phenotype as well as in the brain of a patient affected by another FTDP-17T phenotype: multiple system tauopathy with presenile dementia. Methods: We used immunohistochemical methods to visualize activated microglia, interleukin-1β (IL-1β)-, cyclooxygenase-2 (COX-2)-expressing cells. Results: In the brain of the patient with the P301S mutation, a strong neuroinflammatory reaction was present. Activated microglia/infiltrating macrophages expressing the cluster of differentiation 68 and major histocampatibility complex class II cell surface receptors, encoded by the human leukocyte antigen DP-DQ-DR, were detected in the cortex and hippocampus. IL-1β and COX-2 expression were induced in neuronal and glial cells. These neuroinflammatory changes were different from those observed in the brain of the patient bearing the +3 mutation, where macrophage infiltration was absent, microglial cells displayed an earlier stage of activation and COX-2 was not detected. Conclusions: Our findings suggest that microglial activation and the production of proinflammatory mediators by phospho-tau-positive neurons and glial cells may differentially contribute to neuronal death and disease progression in neurodegenerative tauopathies.

Original languageEnglish
Pages (from-to)221-229
Number of pages9
JournalNeurodegenerative Diseases
Volume8
Issue number4
DOIs
StatePublished - May 2011

Fingerprint

Frontotemporal Dementia
Microglia
Cyclooxygenase 2
Mutation
Brain
Interleukin-1
Neuroglia
Macrophages
Tauopathies
Phenotype
Chromosomes, Human, Pair 17
Parkinsonian Disorders
Cell Surface Receptors
HLA Antigens
Transgenic Mice
Disease Progression
Hippocampus
Neurons

Keywords

  • Cyclooxygenase 2
  • Frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations
  • Interleukin 1β
  • Microglia
  • Neuroinflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation. / Bellucci, Arianna; Bugiani, Orso; Ghetti, Bernardino; Spillantini, Maria Grazia.

In: Neurodegenerative Diseases, Vol. 8, No. 4, 05.2011, p. 221-229.

Research output: Contribution to journalArticle

@article{e767ed35818145148fa9a7bee0c15123,
title = "Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation",
abstract = "Background: Recent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T). Objective: To investigate the occurrence of neuroinflammatory changes in the brain of a patient affected by FTDP-17T associated with the P301S mutation and showing a frontotemporal dementia phenotype as well as in the brain of a patient affected by another FTDP-17T phenotype: multiple system tauopathy with presenile dementia. Methods: We used immunohistochemical methods to visualize activated microglia, interleukin-1β (IL-1β)-, cyclooxygenase-2 (COX-2)-expressing cells. Results: In the brain of the patient with the P301S mutation, a strong neuroinflammatory reaction was present. Activated microglia/infiltrating macrophages expressing the cluster of differentiation 68 and major histocampatibility complex class II cell surface receptors, encoded by the human leukocyte antigen DP-DQ-DR, were detected in the cortex and hippocampus. IL-1β and COX-2 expression were induced in neuronal and glial cells. These neuroinflammatory changes were different from those observed in the brain of the patient bearing the +3 mutation, where macrophage infiltration was absent, microglial cells displayed an earlier stage of activation and COX-2 was not detected. Conclusions: Our findings suggest that microglial activation and the production of proinflammatory mediators by phospho-tau-positive neurons and glial cells may differentially contribute to neuronal death and disease progression in neurodegenerative tauopathies.",
keywords = "Cyclooxygenase 2, Frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations, Interleukin 1β, Microglia, Neuroinflammation",
author = "Arianna Bellucci and Orso Bugiani and Bernardino Ghetti and Spillantini, {Maria Grazia}",
year = "2011",
month = "5",
doi = "10.1159/000322228",
language = "English",
volume = "8",
pages = "221--229",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation

AU - Bellucci, Arianna

AU - Bugiani, Orso

AU - Ghetti, Bernardino

AU - Spillantini, Maria Grazia

PY - 2011/5

Y1 - 2011/5

N2 - Background: Recent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T). Objective: To investigate the occurrence of neuroinflammatory changes in the brain of a patient affected by FTDP-17T associated with the P301S mutation and showing a frontotemporal dementia phenotype as well as in the brain of a patient affected by another FTDP-17T phenotype: multiple system tauopathy with presenile dementia. Methods: We used immunohistochemical methods to visualize activated microglia, interleukin-1β (IL-1β)-, cyclooxygenase-2 (COX-2)-expressing cells. Results: In the brain of the patient with the P301S mutation, a strong neuroinflammatory reaction was present. Activated microglia/infiltrating macrophages expressing the cluster of differentiation 68 and major histocampatibility complex class II cell surface receptors, encoded by the human leukocyte antigen DP-DQ-DR, were detected in the cortex and hippocampus. IL-1β and COX-2 expression were induced in neuronal and glial cells. These neuroinflammatory changes were different from those observed in the brain of the patient bearing the +3 mutation, where macrophage infiltration was absent, microglial cells displayed an earlier stage of activation and COX-2 was not detected. Conclusions: Our findings suggest that microglial activation and the production of proinflammatory mediators by phospho-tau-positive neurons and glial cells may differentially contribute to neuronal death and disease progression in neurodegenerative tauopathies.

AB - Background: Recent findings, showing the presence of an inflammatory process in the brain of transgenic mice expressing P301S mutated human tau protein, indicate that neuroinflammation may contribute to tau-related degeneration in frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations (FTDP-17T). Objective: To investigate the occurrence of neuroinflammatory changes in the brain of a patient affected by FTDP-17T associated with the P301S mutation and showing a frontotemporal dementia phenotype as well as in the brain of a patient affected by another FTDP-17T phenotype: multiple system tauopathy with presenile dementia. Methods: We used immunohistochemical methods to visualize activated microglia, interleukin-1β (IL-1β)-, cyclooxygenase-2 (COX-2)-expressing cells. Results: In the brain of the patient with the P301S mutation, a strong neuroinflammatory reaction was present. Activated microglia/infiltrating macrophages expressing the cluster of differentiation 68 and major histocampatibility complex class II cell surface receptors, encoded by the human leukocyte antigen DP-DQ-DR, were detected in the cortex and hippocampus. IL-1β and COX-2 expression were induced in neuronal and glial cells. These neuroinflammatory changes were different from those observed in the brain of the patient bearing the +3 mutation, where macrophage infiltration was absent, microglial cells displayed an earlier stage of activation and COX-2 was not detected. Conclusions: Our findings suggest that microglial activation and the production of proinflammatory mediators by phospho-tau-positive neurons and glial cells may differentially contribute to neuronal death and disease progression in neurodegenerative tauopathies.

KW - Cyclooxygenase 2

KW - Frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations

KW - Interleukin 1β

KW - Microglia

KW - Neuroinflammation

UR - http://www.scopus.com/inward/record.url?scp=79955871342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955871342&partnerID=8YFLogxK

U2 - 10.1159/000322228

DO - 10.1159/000322228

M3 - Article

C2 - 21212632

AN - SCOPUS:79955871342

VL - 8

SP - 221

EP - 229

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

SN - 1660-2854

IS - 4

ER -